Additional file 2: of Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients

Figure S1 PARK2 alterations. Figure S2 PARK2 mutations. Figure S3 PARK2 mutations in COSMIC. Figure S4 A. Oncomine analysis showed loss of Parkin expression in different types of breast carcinoma cell line in comparison to other cancer cell lines using compendia cell lines data (61 cell lines) ( https://www.oncomine.org/ ). (DOCX 925 kb)